CRISPR-Cas9 Gene Editing for Sickle Cell Disease and beta-Thalassemia. Meisel R. N Engl J Med 2021;384:e91.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Meisel R. CRISPR-Cas9 Gene Editing for Sickle Cell Disease and beta-Thalassemia. N Engl J Med 2021;384:e91.
PMID: 34107195